Switch to:
Pfizer Inc (NYSE:PFE)
Cash Flow for Capital Expenditures
$-1,531 Mil (TTM As of Mar. 2015)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Pfizer Inc's cash flow for capital expenditures for the three months ended in Mar. 2015 was $-246 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2015 was $-1,531 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Pfizer Inc Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Mar. 2015 was -328 (Jun. 2014 ) + -561 (Sep. 2014 ) + -396 (Dec. 2014 ) + -246 (Mar. 2015 ) = $-1,531 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Pfizer Inc Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
Cash Flow_CPEX -2,106-2,203-1,991-1,701-1,205-1,513-1,660-1,419-1,465-1,583

Pfizer Inc Quarterly Data

Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15
Cash Flow_CPEX -586-328-310-328-499-298-328-561-396-246
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK